Condition: Familial Dysautonomia (Riley-Day Syndrome) · Hereditary Sensory and Autonomic Neuropathies · Hereditary Sensory and Autonomic Neuropathy 3 · Sponsor: NYU Langone Health
The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosis and treatment. This is a non-invasive, non-interventional, observation study that poses only minimal risk for participants. The study will document the clinical features of patients with FD overtime by storing their routine clinical test results in a central database. The study will involve collaborators at other specialist clinics around the world who follow/evaluate patients with FD annually. Providing blood for future use is optional.
This description comes directly from the study's public registry record.
Britney A. Paredes Lopez · 2122637225 · Britney.ParedesLopez@nyulangone.org
Horacio Kaufmann, MD · horacio.kaufmann@nyulangone.org
Always discuss trial participation with your own doctor first.
| Dysautonomia Center - School of Medicine -NYU Langone Medical Center | New York, New York, United States | Recruiting |
| Sheba Medical Center - Safra Children's Hospital | Tel Litwinsky, Ramat Gan, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03920774